Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network Formation. by Bargehr, Johannes et al.
Page 1 of 28 
 
Running head: Lineage specificity and smooth muscle cells 
EMBRYOLOGICAL ORIGIN OF HUMAN SMOOTH MUSCLE CELLS 
INFLUENCES THEIR ABILITY TO SUPPORT ENDOTHELIAL NETWORK 
FORMATION 
 Johannes Bargehr*, Lucinda Low*, Christine Cheung, William G Bernard, Dharini Iyer, 
Martin R Bennett, Laure Gambardella and Sanjay Sinha 
The Anne McLaren Laboratory for Regenerative Medicine, West Forvie Building, Forvie 
Site, University of Cambridge, Robinson Way, Cambridge CB2 0SZ,UK 
Division of Cardiovascular Medicine, University of Cambridge, ACCI Level 6, Box 110, 
Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK 
*both authors contributed equally to the work 
Author Contribution: 
Johannes Bargehr: Conception and design, collection and/ or assembly of data, data analysis 
and interpretation, manuscript writing 
Lucinda Low: Conception and design, collection and/ or assembly of data, data analysis and 
interpretation 
Christine Cheung: Conception and design, provision of study material or patients  
William G Bernard: Data analysis and interpretation 
Dharini Iyer: Administrative support, data analysis and interpretation  
Martin R Bennett: Administrative support, data analysis and interpretation 
Laure Gambardella: Data analysis and interpretation  
Sanjay Sinha: Conception and design, financial support, administrative support, data analysis 
and interpretation, final approval of manuscript 
Corresponding Author: 
Dr. Sanjay Sinha 
The Anne McLaren Laboratory for Regenerative Medicine 
West Forvie Building 
Forvie Site 
University of Cambridge 
Robinson Way 
CB2 0SZ Cambridge 
Page 2 of 28 
 
UK 
Tel.: +44 1223 747479 
Fax: +44 1223 763350. 
E-mail address: ss661@cam.ac.uk 
Acknowledgements: This work was supported by the British Heart Foundation (BHF), the 
UK Medical Research Council (MRC) and the Cambridge Hospitals National Institute for 
Health Research Biomedical Research Centre funding. 
Key Words: Embryological Origin, Lineage specific, Smooth Muscle Cells, Endothelial 














Page 3 of 28 
 
ABSTRACT 
Objective: Vascular smooth muscle cells (SMCs) from distinct anatomic locations derive 
from different embryonic origins. Here we investigated the respective potential of different 
embryonic origin-specific SMCs derived from human embryonic stem cells (hESCs) to 
support endothelial network formation in vitro.  
Methods and Results: SMCs of three distinct embryological origins were derived from an 
mStrawberry-expressing hESC line and were co-cultured with GFP-expressing human 
umbilical vein endothelial cells (HUVEC) to investigate the effects of distinct SMC subtypes 
on endothelial network formation. Quantitative analysis demonstrated that LM-derived SMCs 
best supported HUVEC network complexity and survival in 3D co-culture in matrigel. The 
effects of the LM-SMCs on HUVECs were at least in part paracrine in nature. A TaqMan 
Array was performed to identify possible mediators responsible for the differential effects of 
the SMC lineages and a microarray to determine lineage-specific angiogenesis gene 
signatures. Midkine (MDK) was identified as one important mediator for the enhanced 
vasculogenic potency of LM-SMCs. The functional effects of MDK on endothelial network 
formation were then determined by siRNA-mediated knockdown in SMCs, which resulted in 
impaired network complexity and survival of LM-derived SMC co-cultures. 
Conclusions: This is the first study to show that SMCs from distinct embryonic origins differ 
in their ability to support HUVEC network formation. LM-derived SMCs best support 
endothelial cell network complexity and survival in vitro, in part through increased expression 
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1. INTRODUCTION 
Mural cells are essential for the stabilisation and maturation of new endothelial cell networks (1-3). In 
human embryonic development, nascent vascular networks emerge through vasculogenesis and 
angiogenesis. Subsequent stabilisation and maturation of this network is achieved through recruitment 
of mural cells, involving pathways such as the platelet-derived growth factor-BB (PDGF-BB) and 
transforming growth factor beta (TGF-β) (4). The critical role of mural cells has been demonstrated in 
PDGF-BB deficient mice, which developed capillary microaneurysms in the absence of mural cells 
(3). Furthermore abnormal vascular morphogenesis, including changes in microvessel architecture, 
endothelial cell quantity and morphology, and transendothelial permeability, has been described in 
PDGF-BB and PDGF-Rβ deficient mice (5). 
Both cell-cell and paracrine mechanisms are thought to regulate vessel maturation but remain poorly 
characterised (6, 7). In particular, relatively little is known about the effect of the developmental 
origins of mural cells on their signalling to endothelial cells and how this affects vessel development. 
Mural cells have a variety of embryonic origins, which may affect their functional abilities (8, 9). In 
chick embryos, isolated smooth muscle cells (SMC) from the neural crest and from the mesoderm 
exhibit different growth and transcriptional responses to TGF-β (10). Historic in vivo data from chick 
embryos shows that SMC responses are not environment- but lineage-specific. These experiments 
demonstrated that SMCs derived from the nodose placode had a superior ability to replace ablated 
cardiac neural crest SMCs when compared to those of mesodermal origin, corroborating the presence 
of lineage-specific functionality in different SMC populations (11).    
Regenerative cardiovascular medicine is making rapid progress in the treatment of ischaemic or 
dysfunctional tissues through direct cell injection as well as tissue engineered constructs. Adequate 
vascularisation of cellular grafts after transplantation is critical for long term perpetuation of 
homeostasis and functionality for which mural cells are paramount. However to date this topic remains 
poorly addressed and translational approaches would benefit substantially from a better understanding 
of mural cell functionality. Furthermore it remains unknown how the embryonic origin of hESC-
derived SMCs influences vascular network development and what the signalling events involved in 
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this process are. We have previously generated a model of lineage-specific SMC development from 
human embryonic stem cells (hESC) or human induced pluripotent stem cells (iPSC), allowing for 
derivation of mural cells from the lateral mesoderm (LM), the paraxial mesoderm (PM) and the 
neuroectoderm (NE) (12).  
Here we report for the first time that endothelial network formation is substantially determined by the 
embryonic origin of smooth muscle cells. Gene expression profile and microarray data exhibit a 
distinct up-regulation of angiogenesis- or vasculogenesis-related genes in LM-derived SMCs. We 
elucidate the functional role of midkine (MDK) as one mediator of this effect and demonstrate that an 
siRNA-mediated knockdown results in substantially impaired vascular network formation in LM-
derived SMC co-cultures.  
2. EXPERIMENTAL PROCEDURES 
2.1. hESC culture and differentiation  
hESCs (H9, WiCell, Madison) were maintained in a chemically defined medium (CDM-BSA) 
containing Activin-A (10 ng/ml, R&D Systems) and FGF2 (12 ng/ml, R&D Systems) as previously 
described (13). Chemically defined medium consisted of IMDM (250 ml, Life Technologies), Ham’s 
F12 (250 ml, Life Technologies), Pen/Strep (5 ml, Life Technologies), Insulin (350 μl, Roche), 
Transferin (250 μl, Roche), chemically defined 100x lipid concentrate (5 ml, Life Technologies) and 
monothioglycerol (20 μl, Sigma). Differentiation to intermediate lineages and smooth muscle cells 
was performed as previously described in CDM-PVA, containing polyvinyl alcohol (PVA, 1 mg/ml, 
Sigma)(14). In brief, early mesoderm differentiation was started with a combination of CDM-PVA, 
FGF2 (20 ng/ml), LY294002 (10 μM, Sigma) and BMP4 (10 ng/ml, R&D) for 1.5 days. Consequently 
either lateral mesoderm differentiation was started in CDM-PVA, FGF2 (20 ng/ml) and BMP4 (50 
ng/ml) for 3.5 days or paraxial mesoderm differentiation in CDM-PVA, FGF2 (20 ng/ml) and 
LY294002 (10 μM) for 3.5 days. To induce neuroectoderm differentiation, cells were cultured in 
CDM-PVA, FGF (12 ng/ml) and SB431542 (10 μM, Tocris) for 7 days. For smooth muscle cell 
differentiation, LM-, PM- and NE-cells were resuspended as single cells in CDM-PVA, PDGF-BB (10 
ng/ml, Peprotech) and TGF-β1 (2 ng/ml, Peprotech) for 6 days.    
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2.2. Generation of mStrawberry-expressing hESCs  
A lentiviral-based vector was used to allow the transduction of two reporter genes, encoding luciferase 
and the fluorochrome mStrawberry, driven by the constitutively active CAGGS promoter. To produce 
a transduced hES cell line, P64 H9 hESCs were passaged 24 hours prior to lentiviral transduction and 
plated onto gelatine (0.1%) coated 6 well plates. Lentiviral transduction was carried out by addition of 
polycation protamine sulphate (10 μg/ml) and lentivirus at an MOI of 5, or polycation protamine 
sulphate alone as a negative control, to approximately 2x10
5
 cells maintained in CDM with ActivinA 
(10 ng/ml) and FGF2 (12ng/ml). Cells were maintained in culture media for 48 hours and the media 
was changed daily. 24 hours prior to dissociating transduced cells, the culture media was 
supplemented with 10 μM Rho kinase inhibitor (Y-27632, Tocris). 72 hours after transduction, cells 
were incubated in TrypLE Express (Invitrogen) for 5 minutes at 37
°
C, and then dissociated by gentle 
pipetting. Cells were plated onto a 10cm plate that had been coated with 0.1% porcine gelatine and 
contained 1x10
5
 irradiated mouse embryonic fibroblasts as feeder cells (feeder). Cells were maintained 
in DMEM/F12 medium, containing 20% knockout serum replacement and FGF2 (4ng/ml) 
supplemented with Rho kinase inhibitor (10 μM). Colonies that appeared were allowed to expand over 
a 7-day time period. Successfully transduced colonies were identified by fluorescence microscopy, 
picked, and expanded until a stable lentiviral luciferase mStrawberry (LVLS) reporter hES cell line 
was able to be maintained in a feeder free culture system utilising the chemically defined medium as 
described previously. 
2.3. Generation of GFP-expressing HUVECs 
A lentiviral-based vector was used to allow the transduction of reporter gene, EGFP, driven by the 
constitutively active EF-1alpha promoter. To produce GFP-expressing HUVECs, P6 HUVECs were 
passaged 24 hours prior to lentiviral transduction and plated onto T75 flask that had been coated with 
0.1% porcine gelatine. Lentiviral transduction was carried out by addition of polycation protamine 
sulphate (10 μg/ml) and lentivirus at an MOI of 10, or polycation protamine sulphate alone as a 
negative control, to approximately 5x10
5
 cells maintained in human large vessel endothelial cell 
growth medium (Cellworks, Buckingham, UK). Cells were maintained in culture media for 48 hours 
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after transduction and the media was changed daily. This protocol produced a HUVEC cell line with 
99.5% GFP+ cells, as determined by flow cytometry. 
2.4. qRT-PCR 
Total RNA extraction was performed using the GenElute Mammalian Total RNA Miniprep Kit 
(Sigma) and 250 ng of RNA converted to complementary DNA (cDNA) by reverse transcription using 
Maxima First Strand cDNA Synthesis Kit (ThermoFisher) as per the manufacturer’s instructions. 
qRT-PCR reactions were performed with Applied Biosystems 7900HT Fast Real-Time PCR System 
using FAST SYBR Green Master Mix (ThermoFisher) and primers of the target genes. Obtained 
values were normalized to the housekeeping genes GAPDH and PBGD in the same run. Primer 
sequences are depicted in the Supplementary material online, Methods (Table S1). 
2.5. Immunocytochemistry  
Cells were fixed in 4% Paraformaldehyde (PFA) and permeabilised with 0.5% Triton X-100 /PBS. 
This was followed by blocking in 3% BSA/PBS for 45 minutes, at room temperature. Primary 
antibody incubations were performed at 4°C overnight. After incubation with primary antibody, cells 
were washed and incubated with Alexa-Fluor Conjugated secondary antibodies for 45 minutes at room 
temperature. Finally cells were stained with DAPI for 10 minutes to visualize the nuclei. Images were 
acquired on a Zeiss LSM700 using ZEN software. A detailed description of antibodies and dilutions 
used is provided in the Supplementary material online, Methods (Table S2). 
2.6. ELISA 
For ELISA of D6 PT smooth muscle cell supernatant, Human Midkine ELISA Development Kit 
(Peprotech) was used as per the manufacturer’s instructions. Plate readings were obtained on a 2030 
Multilabel Reader (VICTOR X3, Perkin Elmer/Caliper Life Sciences, Hopkinton, MA, USA). 
2.7. 3D co-cultures 
A schematic of this procedure is presented in supplementary figure 1, panel A. GFP-HUVECs and D6 
PT SMCs derived from mStrawberry H9’s were dissociated, centrifuged and resuspended in warm 
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CDM-PVA. Cells were counted and cell combinations were prepared in 15 ml falcon tubes, containing 
either 1.6x10
5
 HUVECs alone, or a combination of 1.6x10
5
 HUVECs and 3.2x10
4
 SMCs (ratio 5:1). 
Cell mixtures were then centrifuged and resuspended in 18 µl ice-cold HUVEC media (TCS 
Cellworks, Cat# M-2953). Tubes were spun down, the supernatant aspirated and resuspended in 18 μl 
ice cold HUVEC media. Subsequently, 20 μl of ice cold Matrigel was added and mixed with the cell 
suspension. Finally 10 μl of each sample were added to each well of a pre-chilled Ibidi Angiogenesis 
µ-Slide (Ibidi, Cat# 81506), in technical triplicates. The slide was incubated for 45 minutes at 37°C 
before adding (volume) warm HUVEC media to each well. Media was refreshed every second day 
throughout the experiment.  
2.8. 3D paracrine assay 
A schematic of this procedure is presented in supplementary figure 1, panel B. For paracrine 3D co-
cultures the 8 outer wells of each 9-well section of 2 Ibidi 2x9 well µ-slides were coated with Matrigel 
and incubated at 37°C for 30 minutes. GFP-HUVECs and D6 PT SMCs derived from mStrawberry 
H9’s were dissociated, centrifuged, and resuspended in CDM-PVA. Cells were counted (6.4x105 
HUVECs or 1.35x10
5
 SMCs) and were transferred to separate 15 ml falcon tubes and centrifuged. 
HUVECs were resuspended in 78 μl ice cold HUVEC media and mixed with 80 μl ice cold Matrigel. 
32 μl of HUVEC suspension were added to the middle wells of the 2x9 well Ibidi µ-slide. Each SMC 
sample was resuspended in 540 μl warm HUVEC media and 60 μl were added to each of the 8 outer 
wells of the µ-slide. For the HUVEC alone sample, media containing no cells was added to the 8 outer 
wells. The slide was incubated for an hour at 37°C to allow the cells to attach and Matrigel to solidify. 
Following this the media was aspirated form all the SMC wells of the μ-slide and the chamber was 
filled with 600 μl of warm endothelial media. Media was refreshed every second day throughout the 
experiment. 
2.9. Confocal Microscopy 
For co-cultures and paracrine assays, images were acquired in technical triplicates per each biological 
replicate. For the siRNA-mediated knockdown of MDK, quantification was further optimised. Three 
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images were taken per each technical replicate, corresponding to 9 images per biological replicate per 
condition. Images were obtained on a Zeiss LSM700 using ZEN software. 
2.10. Image quantification and analysis 
For quantification, three technical replicates, consisting of one image each, were analysed per 
biological replicate. Lsm files were analysed in a blinded fashion with ImageJ. For total network area, 
the images were converted to binary images and the threshold was set until exclusive visualization of 
the network area was obtained. Values obtained reflect μm2. For quantification of total cord length 
lines were manually drawn on the network, their length measured and values converted to μm. Branch 
points were counted manually after transformation of all files into binary images. Data presented as 
bar charts consist of three independent biological replicates, each of which is the average of three 
analysed images (technical replicates).  
2.11. TaqMan Array 
cDNA was synthesized from total RNA samples as described for qRT-PCR. For PCR amplification 
the TaqMan® master mix was combined with the cDNA, loaded on the TaqMan® plate and ran, using 
Applied Biosystems 7900HT Fast Real-Time PCR System.  
2.12. Microarray analysis 
The genes analysed in the TaqMan Human Angiogenesis Array were extracted from our previously 
performed microarray dataset on smooth muscle cells derived from lateral-plate mesoderm, paraxial 
mesoderm, and neuroectoderm after 12 days of PDGF-BB and TGF-β1 treatment (12). Heat maps of 
relative gene expression were generated with Perseus (MaxQuant, v1.4.1.3). Array datasets are 
available from the ArrayExpress microarray data repository under accession number E-MTAB-781. 
2.13. siRNA-mediated knockdown of MDK 
MDK silencer select siRNA was synthesized by Ambion Life Technologies (s8625). As a negative 
control, scrambled (scr) siRNA was used (Silencer Select negative control siRNA, Ambion). SMCs 
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were transfected with 10nM siRNA twice, once on day 11 and once on day 12 (see Supplementary 
material online, Methods).  
2.14. Statistical Analysis 
Results are expressed as mean ± standard error of mean (SEM) of at least three biological replicates of 
independent experiments. Statistical comparisons were carried out using either Student’s T Test for 
two groups of samples or one-way ANOVA with Bonferroni’s post-hoc test in case of multiple group 
comparisons, using Graph Pad Prism Software. Measuring two-sided significance, p-values <0.05 
were considered statistically significant. 
3. RESULTS 
3.1. Generation of embryonic origin-specific intermediates and SMCs for a 3D co-culture with 
human umbilical vein endothelial cells (HUVECs) 
We first generated mStrawberry-expressing hESCs and GFP-expressing HUVECs (Figure S1A and 
S1B). mStrawberry-expressing hESCs were differentiated to LM, PM and NE and subsequently 
treated with PDGF-BB and TGF-β1 (designated as PT) to induce SMC differentiation. On day 13 of 
the protocol, 3D matrigel co-cultures and paracrine assays were set up, in which HUVECs were used 
to model endothelial network formation. The respective potential of lineage-specific mural cells to 
support vasculogenesis was tested using embryonic origin-specific SMCs obtained following 6 days of 
differentiation in PT (Figure 1A). To validate that lineage-specific SMCs were generated and used for 
the matrigel vasculogenesis assays, lineage-specific marker expression was examined at the mRNA 
and protein levels. High expression of the LM markers ISL1 and NKX 2.5 was observed specifically in 
the LM population, as was the specific expression of the PM markers PAX3 and MEOX1 in PM 
(Figure 1B and 1C). Expression of NE markers SOX1 and GBX2 was seen preferentially in NE, as 
shown previously (Figure 1D). In accordance with the mRNA data, LM, PM and NE respectively and 
specifically expressed ISL1, PAX3 and SOX1 at the protein level, as shown by immunocytochemistry 
(Figure S2A-S2C). To show that SMCs were generated from the intermediate lineages, expression of 
SMC markers ACTA2 and CNN1 was demonstrated at the mRNA and protein level before the co-
Page 11 of 28 
 
cultures were started (Figure 1E and S3A-3C). In conclusion, embryonic origin-specific SMCs were 
generated as shown by stage- and lineage-specific marker expression.       
3.2. LM-derived SMCs best support HUVEC network formation in a 3D co-culture model  
To investigate the effects of each SMC lineage on endothelial network formation, 3D co-cultures were 
performed (Figure S4A). To show that mural cells improve endothelial network stability as well as 
complexity, a HUVECs only assay was performed and compared to the other SMC groups. On day 4 
of the co-culture protocol, LM-derived SMCs accounted for the best endothelial network  formation as 
reflected by larger network area, higher total cord length and greater number of branch points, 
compared to PM- and NE-derived SMCs and HUVECs alone (Figure 2A). The effect of the 
differential ability of SMCs to support endothelial network complexity became first apparent on day 2, 
peaked on day 4 and could be observed throughout all time points until day 8. The absolute potential 
of SMCs to provide endothelial network stability became most evident on day 8, when the networks 
consisting of HUVECs alone had disintegrated entirely. As the difference in vasculogenic potency 
between the three lineages was best reflected on day 4, this time point was chosen for further 
endothelial network analysis and quantification. Self-assembly of SMCs and ECs was particularly 
robust in the LM-derived SMC group with the SMCs providing physical support through wrapping 
around the endothelial tubes (Figure 2B). Quantification of this effect demonstrated that LM-derived 
SMC co-cultures had the highest total endothelial network area on day 4 and on day 8, compared to 
the two other SMC lineages and to HUVECs alone (Figure 2C). Furthermore, endothelial networks 
supported by SMCs of the LM origin accounted for a higher total cord length and a higher number of 
branch points than networks co-cultured with the other two SMC lineages, at both time points (Figure 
2D and 2E respectively).  
To elucidate whether this effect was paracrine in nature, 3D paracrine assays were performed. 
HUVECs were plated in the central well of a 9 well chamber and SMCs in the adjacent 8 wells with 
walls separating the wells only half way to the top. This setup allowed for SMC conditioned media but 
not for SMCs to be in physical contact with the endothelial cells. Hence any effect in HUVEC network 
formation observed must be a paracrine but not cell-cell dependent effect (Figure S4B). At day 4 and 
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day 8 of the co-culture timeline, LM-derived SMCs presented as the best supportive cell type for 
endothelial network formation (Figure 3A). Quantification of day 4 of the paracrine assay data showed 
that HUVECs co-cultured with LM-derived SMCs accounted for a greater total endothelial network 
area, with a higher total cord length and more branch points than HUVECs co-cultured with SMCs of 
the two other lineages or HUVECs alone (Figure 3B - 3D). These results suggested that LM-derived 
SMCs best supported endothelial network formation and that this effect was at least partly paracrine in 
nature.   
3.3. Midkine is one mediator of superior vascular network formation in LM-derived SMC co-
cultures and is part of a unique angiogeneic expression pattern 
To identify possible mediators of the LM-derived SMCs’ differential ability to support vascular 
network formation, a TaqMan
©
 Array Human Angiogenesis Panel was performed on D6 PT SMCs 
derived from LM, PM and NE. This assay allows the screening of 94 genes involved in human 
angiogenesis and lymphangiogenesis. After evaluation of all genes, the panel was narrowed down to 
nine candidates which exhibited a selective up-regulation in LM-derived SMCs but not in SMCs of 
PM or NE origin. These included: AMOT, ANGPT1, ANGPTL2, VEGFC, FBLN5, ENPP2, MDK, 
SERPINF1 and PTN (Figure 4A). Validation of the Human Angiogenesis Panel was carried out by 
qRT-PCR and showed a statistically significant up-regulation of AMOT, ANGPTL2, VEGFC, FBLN5 
and MDK selectively in LM-derived SMCs. Compared to the other candidate genes, MDK showed the 
highest statistical significance, when comparing its expression in LM-derived SMCs against 
expression levels in PM- and NE-derived SMCs (Figure 4B). To further corroborate this data we 
analysed a microarray of D12 PT lineage-specific SMCs. The respective heat map is depicted in 
Figure 4C and includes all genes that accounted for an overall statistical significant difference between 
the three SMC lineages (p<0.05). The expression pattern visualised demonstrates that LM-derived 
SMCs up-regulate genes that are not expressed in PM- and NE-derived SMCs, thus comprising a list 
of genes that is uniquely confined to the embryonic origin of the LM lineage (Figure 4C). Analysis of 
the microarray including all of the 94 angiogenesis genes from the TaqMan Array was also performed 
(Figure S5). In summary, MDK was identified as one of 9 candidate genes that were selectively 
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expressed in the LM-derived SMC lineage, which exhibits a lineage specific angiogenic expression 
pattern. 
3.4. SMC-derived MDK regulates vascular network formation in LM-derived SMC and 
HUVEC co-cultures 
To examine the role of MDK in vascular network formation, an siRNA-mediated knockdown was 
performed. MDK siRNA was added to the SMC cultures on day 11 and day 12 of the differentiation 
protocol, before starting the co-cultures with the knocked down SMCs on day 13 (Figure S6A). 
Confirmation of an efficient knockdown of MDK was demonstrated by qRT-PCR and ELISA. In line 
with the results from the TaqMan array, ELISA confirmed that MDK was also selectively expressed in 
LM-derived SMCs at the protein level (Figure S6B and S6C). Co-cultures of MDK-siRNA-treated 
SMCs with endothelial cells revealed substantial phenotypic changes in the LM-derived SMC co-
cultures. Impaired MDK expression resulted in a significant decrease of the total endothelial network 
area of LM-derived SMC co-cultures over a continuous timeline of 4 days (Figure 5A). Extensive 
quantification of this effect revealed a significant decrease in the total endothelial network area of LM-
derived SMC co-cultures over a time period of 4 days. As anticipated, no substantial differences in 
endothelial network formation were seen in co-cultures with SMCs derived from the PM or NE 
(Figure 5B). Knockdown of MDK also resulted in a significant decrease in endothelial network 
complexity, as demonstrated by a significant decrease in total cord length as well as number of branch 
points (Figure 5C and 5D). To confirm our initial finding that LM-derived SMCs promote 
angiogenesis partly in a paracrine fashion, for which one mediator is MDK, we also performed 
paracrine co-cultures with the MDK siRNA treated SMCs. Over a time course of 4 days, MDK 
knockdown selectively impaired endothelial network formation in LM-derived SMC paracrine assays. 
Again no effect of MDK knockdown was seen in PM- and NE-derived SMC co-cultures (Figure 6A). 
Quantification of this effect on day 2 of the paracrine assays showed a significant decrease in total 
endothelial network area and total cord length in the LM-derived SMC group (Figure 6B and 6C). 
Similar to the effect observed in 3D co-cultures, endothelial network complexity in the paracrine assay 
was also decreased, as demonstrated by the decreased number of branch points (Figure 6D).  
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Finally, to examine whether MDK alone in isolation from other angiogenic factors produced by SMCs 
was able to promote human vasculogenesis, 3D matrigel cultures with HUVECs and recombinant 
MDK were performed (Figure 7A). Endothelial networks supplemented with recombinant MDK 
(5000pg/ml) accounted for larger and more complex networks, including a higher total cord length and 
a higher number of branch points than HUVECs alone. This finding corroborates the importance of 
this angiogenic factor in vascular network formation (Figure 7B to 7D). Collectively, this data shows 
that MDK is an important factor in the selective ability of LM-derived SMCs to support human 
vasculogenesis, promoting not only network size but also complexity.  
4. DISCUSSION 
Microvascular network formation has not been devoted major scientific attention in regenerative 
cardiovascular research. However, recent attempts to regenerate ischemic tissue render this field 
highly relevant for the generation of functional tissue grafts in vitro and in vivo. We show for the first 
time that the embryonic origin of mural cells has a functional impact on developing microvascular 
networks, which has implications for regenerative cardiovascular medicine. Specifically, we 
demonstrated that LM-derived SMCs provide superior support to endothelial network formation, 
compared to SMCs originated from the PM or NE. Importantly, microarray and gene expression data 
identified MDK as one mediator of this effect, confirmed by loss- and gain-of-function studies.  
Regenerative medicine has made remarkable progress in its endeavours to regenerate ischaemic and 
dysfunctional body tissues. In the cardiovascular system it has been demonstrated that transplantation 
of hESC-derived cardiomyocytes leads to re-muscularization, electrical coupling and partial 
restoration of cardiac function up to 4 weeks post transplantation in rodents (15, 16). More recently 
heroic efforts in the Murry lab have demonstrated that transplantation of 1 billion cardiomyocytes 
results in robust muscular grafts of infarcted non-human primate hearts (17). However for 
establishment of physiological homeostasis and long term maintenance of graft function, efficient 
vascularisation is likely to be necessary, particularly given that oxygenation by diffusion is only 
sufficient for grafts that are 4-7 cell layers (~100 um) thick (18). Similar reservations apply for tissue-
engineered cardiac constructs which have shown to promote cardiac function after epicardial 
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transplantation to rat hearts in the short term (19). Indeed several studies have shown that 
vascularisation promotes cardiac graft development and maturation (20, 21). However, the potential 
for vascularisation to support regenerative medicine applications will only be realised through a deeper 
understanding of the ability of different cell types to contribute to vasculogenesis, angiogenesis and 
ultimately arteriogenesis.  
Relatively little is known to date about the embryonic origin of mural cells in microvascular 
development. Pericytes comprising the microvasculature of lung, liver and gut have been tracked back 
to mesenchymal origin (22-24) while coronary pericytes originate from the epicardium (25, 26), which 
is a lateral plate mesoderm derivative. In contrast, those composing the micro-cerebrovasculature and 
the thymus derive from the neural crest (27, 28). A number of investigators have shown lineage-
dependent functional differences for SMCs comprising large vessels. For NE-derived SMCs a 
functional lineage specific response was shown after Angiotensin II treatment (29) and differentiation 
of this lineage revealed myocardin-related transcription factor B (MKL2) as sine qua non (10). 
However it remains unknown whether lineage-specific effects of mural cells exist in microvascular 
development. Due to the high prevalence and rising incidence of diseases involving pathologies in the 
microvasculature, it is of great interest to elucidate the nature and mediators of lineage specific effects 
in endothelial network formation. Furthermore this information might aid attempts to revascularise 
ischemic body tissues and to bioengineer tissue constructs for regenerative purposes.  
Searching for possible mediators of the ability of LM-derived SMCs to better support vascular 
network formation, we made use of a TaqMan Array Human Angiogenesis Panel. Validation of this 
assay by qRT-PCR revealed that MDK was one of five genes that showed a statistically significant up-
regulation in LM-derived SMCs. MDK is a well-studied target in oncology with a direct correlation of 
its expression levels and microvessel density in salivary gland tumours and oral squamous cell 
carcinomas (30, 31). An MDK transfected Breast Carcinoma Cell line was reported to exhibit a greater 
vascular density and a higher tumor and endothelial cell proliferative index compared to a mock-
transfected control cell line (32). In line with these findings it has been shown that high expression 
levels in patients with invasive bladder cancer correlate with poor survival (33).   
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In our human in vitro system, knockdown of MDK resulted in significantly impaired vascular network 
formation. Suggesting a role in angiogenesis, MDK-deficient mice have been shown to exhibit less 
lung metastasis of Lewis lung carcinoma cells and reduced tumorigenesis of neuroblastomas (34, 35). 
In the cardiovascular field, MDK injection, as well as MDK gene transfer, into post-infarcted rat 
hearts has been demonstrated to decrease cardiac remodelling through anti-apoptotic and pro-
vasculogenic effects (36, 37). However, these studies investigated the formation of endothelial cell 
networks without taking into account the effect of mural cells. In addition, it has not yet been 
demonstrated that SMCs and their embryonic origins play key roles in the production of this cytokine. 
Our model is the first of its kind that provides an important insight into the functional role of MDK 
during embryonic vascular development in a human system.  
Here we have also shown that support through LM-derived SMCs results in a more developed 
endothelial network, reflected in a higher number of branch points. Of note, knockdown of MDK 
resulted in fewer vascular branch points and supplementation of recombinant MDK supported network 
formation in HUVEC monocultures similar to those seen in LM-derived SMC co-cultures. These 
results indicate that MDK is involved in generating a complex, branched endothelial network. At the 
same time HUVECs alone appear to form larger and less complex endothelial cords. In the context of 
vascular network formation, the role of VEGF and Notch in tip and stalk cell specification and 
vascular patterning has extensively been described, but the role of MDK remains unknown (38-43).  
In the current study we have provided microarray data of lineage-specific D12 PT SMCs and shown 
that the three SMC lineages account for individual angiogenic gene expression signatures. While our 
3D endothelial network formation assay focuses on early vascular development by using D6 PT 
SMCs, we were able to coherently show that more mature SMCs express the same genes as on D6 of 
SMC differentiation with PT and additionally up-regulate others by D12. This Taqman array and 
microarray provide a valuable library of targets to study in the context of vascular network formation. 
Thus, other putative mediators of the beneficial effects of LM-derived SMC on endothelial network 
formation include Angiomotin (AMOT), Angiopoietin-like protein 2 (ANGPTL2), Fibulin 5 (FBLN5) 
and Vascular endothelial growth factor C (VEGF-C).  
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In the current study we have chosen matrigel to study the effects of mural cells on endothelial network 
formation. At the same time we wanted to elucidate key signals responsible for the differential ability 
of embryonic origin specific SMC lineages to allow for superior survival and growth of more complex 
endothelial networks. Matrigel assays are a widely used tool to study EC network formation and EC-
mural cell crosstalk and are used as such by leading vascular laboratories around the world (44-48).  In 
this context matrigel has been well established as a cord forming assay. While there are limitations 
regarding lumen formation the main objective of this study was to investigate branching and survival 
in a 3D context, which was well served by the system used. Of note we demonstrated that LM-derived 
SMC also allow for growth of more complex endothelial networks with a higher number of branch 
points, which is not a mere consequence of superior survival but a reflection of the angiogenic effect 
of MDK, which was confirmed by loss and gain of function studies.  
The fact that LM-derived SMCs exhibit the best supportive function is not surprising because they 
emerge from a unique embryonic origin and express different sets of genes that are implicated in 
vasculogenesis. Whether these observations have an impact in vivo is a question that has to date not 
been addressed. In this regard it would be of interest to evaluate the vasculogenic potential of lineage-
specific SMCs in a wound healing assay in vivo.  
While this study is the first to demonstrate that the lineage specificity of mural cells has a functional 
impact on developing endothelial networks, it remains to be seen how endothelium from different 
vascular beds interacts with smooth muscle cells of different types. Recent studies have shown that 
endothelial cells from different vascular territories display unique properties and indeed these different 
endothelial cell populations have been demonstrated to have unique, tissue specific signatures (49). 
However, it is unclear how these signatures are obtained; either through different intermediate 
developmental steps taken by the angioblasts, or a direct effect of the tissue specific 
microenvironment. Further studies should investigate how to generate tissue specific endothelial cells 
and whether these show distinct responses to the lineage-specific SMCs we have established. In this 
regard one future endeavour of tissue engineering and regenerative medicine will be the generation of 
embryonically and physiologically relevant body tissues in which lineage specific vascular cells will 
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play a key role.  
5. CONCLUSION 
Taken collectively we have demonstrated that the embryonic origin of mural cells has a functional 
impact in endothelial network development, complexity and survival for which MDK is one important 
mediator. Fully exploiting the lineage-specific functionality of mural cells may prove critical for 
vascular tissue engineering and therapeutic revascularisation. 
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FIGURE TITLES AND LEGENDS 
Fig. 1. Generation of embryonic origin specific SMC populations for a 3D co-culture 
model. (A) Schematic representation of the in vitro differentiation of embryonic origin-
specific SMCs. Neuroectoderm (NE) was differentiated from hESCs using FGF2+SB431542 
(FSB) treatment for 7 days. hESCs were also differentiated to early mesoderm in 
FGF2+LY294002+BMP4 (FlyB) for 36 hr and subsequently to lateral mesoderm (LM) in 
FGF2+BMP4 (FB50) or paraxial mesoderm (PM) in FGF2+LY294002 (Fly) for 3.5 days. For 
further differentiation into vascular SMCs, each of the three intermediate lineages was 
subjected to PDGF-BB+TGF-β (PT) treatment for 6 days, then co-cultured with HUVECs. 
(B-D) Validation of the identity of the intermediate lineages, LM, PM and NE respectively, by 
qRT-PCR analysis of lineage specific markers (n=3). (E) SMC marker expression in D6 PT 
treated SMCs by qRT-PCR (*p<0,05, **p<0,01, ***p<0,001, ****p<0.0001, n=3 
independent biological replicates). 
Fig. 2. LM-derived SMCs best support HUVEC network formation in a 3D co-culture 
model. (A) Confocal images of HUVEC (green) co-cultures with the three respective SMC 
types (red) on day 4 and day 8 of the co-culture protocol. (B) SMCs provide physical support 
to developing networks, wrapping around endothelial network. (C) Quantification of total 
network area in μm2. (D) Quantification of total cord length. (E) Quantification of number of 
branch points. Quantitative data is shown for day 4 of the co-culture (*p<0,05, **p<0,01, 
***p<0,001, n=3 independent biological triplicates, scale bars= 100 μm). 
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Fig. 3. Paracrine effects of lineage-specific SMCs on HUVEC networks. HUVECs were 
exposed to supernatant conditioned by lineage specific SMCs (as depicted in fig. S4B). (A) 
Confocal images of paracrine co-cultures taken on day 4 and day 8 of the protocol. (B) 
Quantification of total network area in μm
2
. (C) Quantification of total cord length. (D) 
Quantification of number of branch points. Quantitative data is shown for day 4 of the co-
culture (*p<0,05, **p<0,01, ***p<0,001, n=3 independent biological replicates, scale bars= 
100 μm). 
Fig. 4. Putative mediators of network formation identified by TaqMan
©
 Array and 
microarray. (A) Candidate genes differentially up-regulated in LM-derived SMCs as per 
Taqman Array Human angiogenesis panel. Transfection of scrambled siRNA (siScr) was used 
as negative control. (B) Validation of the TaqMan
©
 Array by qRT-PCR. (C) Lineage-specific 
gene signatures of the three embryonic origin specific SMC lines per microarray. MDK is 
highlighted in red. Red (upregulation) and blue (downregulation) reflect expression from the 
mean across all samples (*p<0,05, **p<0,01, ***p<0,001, n=3 independent biological 
replicates). 
Fig. 5. siRNA-mediated knockdown of MDK in 3D co-cultures. (A) Effect of MDK 
knockdown in SMCs on HUVEC network formation in 3D co-culture as per confocal 
microscopy over a 4 day timeline. Transfection of scrambled siRNA (siScr) was used as 
negative control. (B) Quantification of the effect of MDK siRNA-mediated knockdown on 
total network area in co-cultures of the three SMC lineages on day 2. (C) Quantification of 
total cord length in co-cultures containing MDK-siRNA treated SMCs on day 2. (D) 
Quantification of the effect of MDK siRNA-mediated knockdown on the number of branch 
points in co-cultures of the three SMC lineages on day 2. (*p<0,05, **p<0,01, ***p<0,001, 
n=3 independent biological replicates, scale bars= 100 μm). 
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Fig. 6. siRNA-mediated knockdown of MDK in 3D paracrine assays. (A) Effect of MDK 
knockdown in SMC on HUVEC network formation in 3D paracrine co-culture as per confocal 
microscopy over a 4 day timeline. (B) Quantification of the effect of MDK siRNA-mediated 
knockdown on total HUVEC network area in co-cultures with the three SMC lineages on day 
2. (C) Quantification of total cord length in co-cultures containing MDK-siRNA treated SMCs 
on day 2. (D) Quantification of the effect of MDK siRNA-mediated knockdown on the 
number of branch points in co-cultures of the three SMC lineages on day 2. (*p<0,05, 
**p<0,01, ***p<0,001, n=3 independent biological replicates, scale bars= 100 μm). 
Fig. 7. Addition of recombinant MDK in 3D HUVEC mono-cultures. (A) Effect of 
recombinant MDK on HUVEC network formation in 3D HUVEC monocultures as per 
confocal microscopy over a 4 day timeline. Quantification of the effect of recombinant MDK 
(B) on total network area in HUVEC monocultures on day 2; (C) on total cord length on day 
2; and (D) on the number of branch points on day 2 (*p<0,05, **p<0,01, ***p<0,001, n=3 
independent biological replicates, scale bars= 100 μm). 
Supplementary figure legends: 
Fig. S1. Generation of mStrawberry-expressing hESCs. (A) Flowcytometry of 
mStrawberry expressing hESCs. (B) Immunocytochemistry of mStrawberry expressing 
hESCs. 
Fig. S2. Generation of embryonic origin specific SMC populations for a 3D co-culture 
model. (A-C) Immunocytochemistry of the LM, PM and NE intermediate lineages derived 
from an m-Strawberry expressing H9 line (*p<0,05, **p<0,01, ***p<0,001, n=3 independent 
biological replicates, scale bars 100 μm). 
Fig. S3. Lineage specific SMC derivation. (A-C) Immunocytochemistry of lineage-specific 
SMCs of an m-Strawberry expressing H9 line, derived from NE-, LM- and PM-lineage 
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respectively (*p<0,05, **p<0,01, ***p<0,001, n=3 independent biological replicates, scale 
bars 50 μm). 
Fig. S4. Schematic of 3D co-culture and 3D paracrine assay. (A) Schematic cross section 
of a 3D co-culture of  HUVECS (green) and embryonic origin specific SMCs (red). (B) 
Schematic representation of a 3D paracrine assay containing HUVECs in the central well and 
embryonic origin specific SMCs in the surrounding wells, allowing for exchange of the 
supernatant but not for cell-cell contact. 
Fig. S5. Microarray analysis. (A) Heat map of all angiogenesis genes as expressed by the 
three embryonic origin specific smooth muscle cells lineages. MDK highlighted in red. 
Fig. S6. Confirmation of siRNA-mediated knockdown of MDK in embryonic origin 
specific SMCs. (A) Schematic of SMC differentiation and timing of MDK siRNA 
intervention. (B) Confirmation of effective knockdown of MDK by qRT-PCR. (C) 
Confirmation of effective knockdown of MDK by ELISA (*p<0,05, **p<0,01, ***p<0,001, 
n=3 independent biological replicates). 
 
